http://www.unboundmedicine.com/medline/ebm/research/ganirelixUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19860353/full_citation/The_effect_of_cetrorelix_vs__ganirelix_on_pregnancy_outcome_using_minimal_gonadotropin_stimulation_in_women_with_elevated_day_3_serum_follicle_stimulating_hormone_levels_Check JH, Brasile D, Choe JK, et al. 
The effect of cetrorelix vs. ganirelix on pregnancy outcome using minimal gonadotropin stimulation in women with elevated day 3 serum follicle stimulating hormone levels. [Journal Article]
Clin Exp Obstet Gynecol 2009; 36(3):148-9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19712548/full_citation/GnRH_antagonist_ganirelix_prevents_premature_luteinization_in_IUI_cycles:_rationale_for_its_use_Martinez-Salazar J, Cerrillo M, Quea G, et al. 
GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use. [Journal Article, Research Support, Non-U.S. Gov't]
Reprod Biomed Online 2009 Aug; 19(2):156-61.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19608177/full_citation/Treatment_of_ovarian_hyperstimulation_syndrome_using_a_dopamine_agonist_and_gonadotropin_releasing_hormone_antagonist:_a_case_series_Rollene NL, Amols MH, Hudson SB, et al. 
Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series. [JOURNAL ARTICLE]
Fertil Steril 2009 Jul 14.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19438162/full_citation/Predictors_and_implications_of_estradiol_rise_after_gonadotropin_releasing_hormone_antagonist_initiation_during_in_vitro_fertilization_cycles_Scotchie JG, Will M, Fritz MA, et al. 
Predictors and implications of estradiol rise after gonadotropin-releasing hormone antagonist initiation during in vitro fertilization cycles. [Journal Article]
J Reprod Med 2009 Apr; 54(4):211-7.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19230256/full_citation/[Ovulation_triggering_in_high_risk_IVF_patients:_GnRH_ag_diminished_dose_of_urinary_or_recombinant_ChG][Ovulation triggering in high risk IVF patients: GnRH-ag, diminished dose of urinary or recombinant ChG] [English Abstract, Journal Article]
Akush Ginekol (Sofiia) 2008; 47(5):3-6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19227761/full_citation/[Protocole_with_GnRH_antagonist_and_ovulation_trigger_with_GnRH_agonist_in_risk_patients__a_reliable_method_of_prophylactic_of_OHSS][Protocole with GnRH-antagonist and ovulation trigger with GnRH-agonist in risk patients--a reliable method of prophylactic of OHSS] [English Abstract, Journal Article]
Akush Ginekol (Sofiia) 2008; 47(4):16-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19200979/full_citation/Gonadotropin_releasing_hormone_antagonist_use_in_controlled_ovarian_stimulation_and_intrauterine_insemination_cycles_in_women_with_polycystic_ovary_syndrome_Ertunc D, Tok EC, Savas A, et al. 
Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome. [JOURNAL ARTICLE]
Fertil Steril 2009 Feb 5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19176542/full_citation/In_GnRH_antagonist/rec_FSH_stimulated_cycles_advanced_endometrial_maturation_on_the_day_of_oocyte_retrieval_correlates_with_altered_gene_expression_Van Vaerenbergh I, Van Lommel L, Ghislain V, et al. 
In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression. [Journal Article, Research Support, Non-U.S. Gov't]
Hum Reprod 2009 May; 24(5):1085-91.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18983747/full_citation/Predictors_of_ovarian_response_in_intrauterine_insemination_patients_and_development_of_a_dosage_nomogram_Freiesleben NL, Lossl K, Bogstad J, et al. 
Predictors of ovarian response in intrauterine insemination patients and development of a dosage nomogram. [Journal Article, Research Support, Non-U.S. Gov't]
Reprod Biomed Online 2008 Nov; 17(5):632-41.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18946098/full_citation/Endometrial_thickness_dynamics_and_morphologic_characteristics_during_pituitary_downregulation_with_antagonists_in_assisted_reproductive_technology_cycles_Detti L, Yelian FD, Kruger ML, et al. 
Endometrial thickness dynamics and morphologic characteristics during pituitary downregulation with antagonists in assisted reproductive technology cycles. [Journal Article]
J Ultrasound Med 2008 Nov; 27(11):1591-6.
Abstract | Full Citation | Find Related Articles